Compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates

A compound of formula (I):

• (I)
• or stereoisomers, racemic mixtures, tautomers, pharmaceutically acceptable salts, thereof;
• wherein
• A is selected from the group consisting of
• wherein
• can be attached to the N atom at any available position;
• B is NRa;
• E and V are independently selected from the group consisting of N, NR5, O and S;
• G is selected from the group consisting of a benzene ring and a pyridine ring;
• Y, Y1, Y2 and Y3 are CZ;
• Z is independently selected from the group consisting of H, halogen, O-alkyl, alkyl and CN;
• R is independently selected from the group consisting of
• and —NR3R4;
• Ra is selected from the group consisting of H and alkyl;
• Rd, Re, Rf, and Rg are H;
• R2 is independently selected from the group consisting of alkyl and —O-alkyl, wherein if two R2 are geminal they can be joined to form a 3 to 6-membered ring;
• R3 and R4 are independently selected from the group consisting of H and alkyl;
• R5 is selected from the group consisting of H and alkyl;
• and
• n is 0, 1, 2, 3 or 4.